Exalt (EXALT) Q2 2026 earnings summary

Executive summary

• Q2 2026 was challenging with low sales and one-time restructuring costs totaling 1.8 MSEK, including 1.5 MSEK for personnel and 0.3 MSEK for a customer receivable write-down.

• Strategic restructuring measures were implemented to strengthen future competitiveness and long-term development.

• A loan of 3.0 MSEK was secured from the largest shareholder to ensure continued stability and development.

Financial highlights

• Q2 2026 net sales: 10.3 MSEK (down from 13.5 MSEK in Q2 2025).

• Q2 2026 EBITDA: -2.6 MSEK (0.2 MSEK in Q2 2025); EBIT: -2.7 MSEK (0.1 MSEK in Q2 2025).

• H1 2026 net sales: 20.7 MSEK (26.8 MSEK in H1 2025); EBITDA: -3.2 MSEK (0.4 MSEK in H1 2025); EBIT: -3.4 MSEK (0.3 MSEK in H1 2025).

• Period result Q2 2026: -2.8 MSEK (0.1 MSEK in Q2 2025); H1 2026: -3.5 MSEK (0.1 MSEK in H1 2025).

• Cash and cash equivalents at June 30: 1.9 MSEK (1.7 MSEK in prior year).

Outlook and guidance

• Focus remains on profitability first, then sustainable growth.

• Restructuring efforts expected to continue impacting Q3, with positive effects anticipated from Q4.

• No further financing needs are currently anticipated to reach positive cash flow and profitability.